An appraisal of meta-analysis guidelines: how do they relate to safety outcomes?

被引:8
作者
Bennetts, Meg [1 ]
Whalen, Ed [2 ]
Ahadieh, Sima [3 ]
Cappelleri, Joseph C. [4 ]
机构
[1] Pfizer Ltd, Global Pharmacometr, Sandwich, Kent, England
[2] Pfizer Inc, Stat, New York, NY USA
[3] Pfizer Inc, Global Pharmacometr, Groton, CT USA
[4] Pfizer Inc, Stat, Groton, CT USA
关键词
systematic review; network meta-analysis; safety data; meta-analysis; data quality; RANDOMIZED CONTROLLED-TRIALS; CARE DECISION-MAKING; ISPOR TASK-FORCE; DRUG SAFETY; CELECOXIB; EVENTS;
D O I
10.1002/jrsm.1219
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although well developed to assess efficacy questions, meta-analyses and, more generally, systematic reviews, have received less attention in application to safety-related questions. As a result, many open questions remain on how best to apply meta-analyses in the safety setting. This appraisal attempts to: (i) summarize the current guidelines for assessing individual studies, systematic reviews, and network meta-analyses; (ii) describe several publications on safety meta-analytic approaches; and (iii) present some of the questions and issues that arise with safety data. A number of gaps in the current quality guidelines are identified along with issues to consider when performing a safety meta-analysis. While some work is ongoing to provide guidance to improve the quality of safety meta-analyses, this review emphasizes the critical need for better reporting and increased transparency regarding safety data in the systematic review guidelines. Copyright (C) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:64 / 78
页数:15
相关论文
共 43 条
[21]   A tool to assess the quality of a meta-analysis [J].
Higgins, Julian P. T. ;
Lane, Peter W. ;
Anagnostelis, Betsy ;
Anzures-Cabrera, Judith ;
Baker, Nigel F. ;
Cappelleri, Joseph C. ;
Haughie, Scott ;
Hollis, Sally ;
Lewis, Steff C. ;
Moneuse, Patrick ;
Whitehead, Anne .
RESEARCH SYNTHESIS METHODS, 2013, 4 (04) :351-366
[22]   Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2 [J].
Hoaglin, David C. ;
Hawkins, Neil ;
Jansen, Jeroen P. ;
Scott, David A. ;
Itzler, Robbin ;
Cappelleri, Joseph C. ;
Boersma, Cornelis ;
Thompson, David ;
Larholt, Kay M. ;
Diaz, Mireya ;
Barrett, Annabel .
VALUE IN HEALTH, 2011, 14 (04) :429-437
[23]   The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations [J].
Hutton, Brian ;
Salanti, Georgia ;
Caldwell, Deborah M. ;
Chaimani, Anna ;
Schmid, Christopher H. ;
Cameron, Chris ;
Ioannidis, John P. A. ;
Straus, Sharon ;
Thorlund, Kristian ;
Jansen, Jeroen P. ;
Mulrow, Cynthia ;
Catala-Lopez, Ferran ;
Gotzsche, Peter C. ;
Dickersin, Kay ;
Boutron, Isabelle ;
Altman, Douglas G. ;
Moher, David .
ANNALS OF INTERNAL MEDICINE, 2015, 162 (11) :777-784
[24]   Efficacious treatment of psoriasis with low-dose and intermittent cyclosporin microemulsion therapy [J].
Ito, Taisuke ;
Furukawa, Fukumi ;
Iwatsuki, Keiji ;
Matsue, Hiroyuki ;
Shimada, Shinji ;
Takigawa, Masahiro ;
Tokura, Yoshiki .
JOURNAL OF DERMATOLOGY, 2014, 41 (05) :377-381
[25]   Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report [J].
Jansen, Jeroen P. ;
Trikalinos, Thomas ;
Cappelleri, Joseph C. ;
Daw, Jessica ;
Andes, Sherry ;
Eldessouki, Randa ;
Salanti, Georgia .
VALUE IN HEALTH, 2014, 17 (02) :157-173
[26]   Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1 [J].
Jansen, Jeroen P. ;
Fleurence, Rachael ;
Devine, Beth ;
Itzler, Robbin ;
Barrett, Annabel ;
Hawkins, Neil ;
Lee, Karen ;
Boersma, Cornelis ;
Annemans, Lieven ;
Cappelleri, Joseph C. .
VALUE IN HEALTH, 2011, 14 (04) :417-428
[27]  
Loke YK, 2011, COCHRANE HDB SYSTEMA
[28]  
Moher D, 2010, INT J SURG, V8, P336, DOI [10.1016/j.ijsu.2010.02.007, 10.1371/journal.pmed.1000097, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700]
[29]   Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis [J].
Ohlssen, David ;
Price, Karen L. ;
Xia, H. Amy ;
Hong, Hwanhee ;
Kerman, Jouni ;
Fu, Haoda ;
Quartey, George ;
Heilmann, Cory R. ;
Ma, Haijun ;
Carlin, Bradley P. .
PHARMACEUTICAL STATISTICS, 2014, 13 (01) :55-70
[30]   Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials [J].
Paul, M ;
Yahav, D ;
Fraser, A ;
Leibovici, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (02) :176-189